Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$71,695,082
+$29,194,406 QoQ
Shares Held
1,495,517
+29.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#44
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. NVO ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,695,082 | 1,495,517 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $42,500,676 | 1,156,481 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $64,500,574 | 1,267,700 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $51,015,949 | 919,372 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $79,162,416 | 1,146,949 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,461,177 | 1,187,517 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $130,506,702 | 1,517,167 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $209,240,517 | 1,757,290 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $252,939,844 | 1,772,032 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $217,935,372 | 1,697,316 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $168,119,385 | 1,625,127 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $138,724,420 | 1,525,450 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $120,618,369 | 745,340 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $159,591,797 | 1,002,839 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $163,681,817 | 1,209,412 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $121,754,531 | 1,222,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $138,155,925 | 1,239,845 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $130,226,443 | 1,172,683 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $116,792,368 | 1,042,789 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $97,237,101 | 1,012,781 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $81,305,652 | 970,582 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $63,052,934 | 935,226 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $55,979,672 | 801,427 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $53,968,076 | 777,302 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $50,081,393 | 764,835 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,828,164 | 412,428 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||